Here are some questions to think about as you review this study: What adverse events were associated with the use of atorvastatin? Are these results externally valid and applicable to your patients diagnosed with ischemic stroke or TIA? How was…
Test and review your knowledge about VTE and management with anticoagulation.
What’s your differential diagnosis to explain the “strange behavior” of a patient with newly diagnosed HIV/AIDS?
Do you ever give NSAID’s to patients with cardiomyopathy? Usually not, and here is evidence supporting why we don’t. But are there some NSAID’s that have less unfavorable outcomes?
Lactulose is widely used for treatment of hepatic encephalopathy because it is effective, cheap, and widely available. So is there any benefit to using Rifaximin in patients with hepatic encephalopathy? Here are some questions to answer when reviewing this article…
Thank you, Alex, for a review of outcome data for one of the newest diabetes medications: canaglifozin (Invokana®). Canaglifozin is a SGLT2 inhibitor, which decreases reabsorption of glucose in the renal tubules. Clinical Question: Among patients with DM2 at high risk…
Key Discussion Points: Early treatment of acute heart failure with loop diuretics lowers mortality despite initial mortality risk, and this treatment strategy might be even more effective in high-risk AHF patients Earlier treatment/identification of acute heart failure relied heavily on…
Notifications